Projects per year
Personal profile
Biography
Professor Brendan Jenkins
Head - Cancer and Immune Signalling Laboratory
Centre for Innate Immunity and Infectious Diseases
NHMRC Senior Research Fellow
Brendan is Head of the Cancer and Immune Signalling Laboratory in the Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, and currently holds a prestigious NHMRC Senior Research Fellowship. His research laboratory has a strong focus on cancer (stomach, lung, pancreatic) and immune-related diseases (emphysema/COPD, arthritis, peritonitis).
Prof Brendan Jenkins is a current NHMRC Senior Research Fellow and prior to this he was holder of an NHMRC RD Wright Postdoctoral Research Fellowship, a Monash University Fellowship, and most recently a prestigious Sylvia and Charles Viertel Senior Medical Research Fellowship.
Over the last 15 years he has been at the forefront of research to examine the roles cytokines play in human disease, in particular cancer of the stomach (gastric cancer) which is the second most lethal cancer world-wide, and chronic inflammation. Since being recruited to the Hudson Institute, he further expanded his research to also include cancers of the lung (most common and lethal cancer in the world) and pancreas (worst survival rates worldwide), as well as the debilitating lung disease emphysema/chronic obstructive pulmonary disease (COPD). Collectively, his research programs incorporate long standing collaborations with basic scientific researchers, industry and clinicians both nationwide and overseas (UK, Japan, Singapore, Europe). Amongst his scientific achievements are publications in the highest ranking science and medical research journals including Cancer Cell, Nature, Nature Medicine, Immunity, Journal of Clinical Investigation, Journal of Experimental Medicine, Cancer Research, Oncogene, and Journal of Immunology.
In recognition of his group's research achievements, he has received numerous national and international awards, including the Australian Institute for Policy and Science Tall Poppy Award. He is a holder of multiple project grants within Australia (NHMRC, Cancer Council) and overseas (Association for International Cancer Research), and is a regular invited speaker at local and international scientific meetings.
Research area keywords
- Animal Disease Models
- Cancer
- Cytokine Signal Transduction
- Emphysema
- Gastric (Stomach) Cancer
- Inflammation
- Inflammatory diseases
- Interleukin (Il)-6 Family Cytokines
- Lung Cancer
- Pattern Recognition Receptors
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2006 2023
Using next generation sequencing technology to improve the diagnosis of pancreatic cancer
Croagh, D., Southey, M., Jenkins, B., Segelov, E., Rathi, V., Holt, B. A., Pilgrim, C., Bhutani, M. & Tagkalidis, P.
15/02/19 → 14/02/23
Project: Research
Targeting key regulators of innate immunity in inflammation-associated cancer
1/01/19 → 31/12/23
Project: Research
Specific targeting of the TACE protease as a therapeutic strategy in lung adenocarcinoma and associated cachexia
Jenkins, B. & Rose-John, S.
15/07/18 → 14/07/20
Project: Research
Novel role of innate immune DNA sensors in promoting gastric cancer
Jenkins, B. & Tan, P.
1/01/18 → 31/12/21
Project: Research
FPR2 is a therapeutic target in lung cancer
Bozinovski, S., Jenkins, B., Vlahos, R., Irving, L., Steinfort, D. P. & Levy, B. D.
1/01/18 → 31/12/21
Project: Research
Research Output 1998 2019
1
Citation
(Scopus)
ADAM17: An emerging therapeutic target for lung cancer
Saad, M. I., Rose-John, S. & Jenkins, B. J., 21 Aug 2019, In : Cancers. 11, 9, 28 p., 1218.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
2
Citations
(Scopus)
ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer
Saad, M. I., Alhayyani, S., McLeod, L., Yu, L., Alanazi, M., Deswaerte, V., Tang, K., Jarde, T., Smith, J. A., Prodanovic, Z., Tate, M. D., Balic, J. J., Watkins, D. N., Cain, J. E., Bozinovski, S., Algar, E., Kohmoto, T., Ebi, H., Ferlin, W., Garbers, C. & 4 others, , Apr 2019, In : EMBO Molecular Medicine. 11, 4, 19 p., e9976.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
6
Citations
(Scopus)
Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice
Han, T. S., Voon, D. C. C., Oshima, H., Nakayama, M., Echizen, K., Sakai, E., Yong, Z. W. E., Murakami, K., Yu, L., Minamoto, T., Ock, C. Y., Jenkins, B. J., Kim, S. J., Yang, H. K. & Oshima, M., 1 Mar 2019, In : Gastroenterology. 156, 4, p. 1140-1155.e4 20 p.Research output: Contribution to journal › Article › Research › peer-review
Serine-phosphorylated STAT3 promotes tumorigenesis via modulation of RNA polymerase transcriptional activity
Balic, J. J., Garama, D. J., Saad, M. I., Yu, L., West, A. C., West, A. J., Livis, T., Bhathal, P. S., Gough, D. J. & Jenkins, B. J., 15 Oct 2019, In : Cancer Research. 79, 20, p. 5272-5287 16 p.Research output: Contribution to journal › Article › Research › peer-review
3
Citations
(Scopus)
Toll-like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2
Liu, Y. D., Yu, L., Ying, L., Balic, J., Gao, H., Deng, N. T., West, A., Yan, F., Ji, C. B., Gough, D., Tan, P., Jenkins, B. J. & Li, J. K., 15 Jun 2019, In : International Journal of Cancer. 144, 12, p. 3056-3069 14 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File